According to Dynavax Technologies 's latest financial reports the company's current EPS (TTM) is $0.87. In 2022 the company made an earnings per share (EPS) of $2.31 an increase over its 2021 EPS that were of $0.61.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.87 | -62.34% |
2022 | $2.31 | 278.69% |
2021 | $0.61 | -178.21% |
2020 | -$0.78 | -64.71% |
2019 | -$2.21 | -13.33% |
2018 | -$2.55 | 38.59% |
2017 | -$1.84 | -36.77% |
2016 | -$2.91 | -11.55% |
2015 | -$3.29 | -4.64% |
2014 | -$3.45 | -9.92% |
2013 | -$3.83 | -6.59% |
2012 | -$4.10 | 5.13% |
2011 | -$3.90 | -43.48% |
2010 | -$6.90 | -9.21% |
2009 | -$7.60 | 46.15% |
2008 | -$5.20 | -65.56% |
2007 | -$15.10 | -6.21% |
2006 | -$16.10 | 106.41% |
2005 | -$7.80 | -8.24% |
2004 | -$8.50 | -91.53% |
2003 | -$100.40 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Pfizer PFE | $1.86 | 113.79% | ๐บ๐ธ USA |
Amgen AMGN | $14.15 | 1,526.44% | ๐บ๐ธ USA |
Biogen BIIB | $18.46 | 2,021.84% | ๐บ๐ธ USA |
Gilead Sciences GILD | $4.39 | 404.60% | ๐บ๐ธ USA |
Merck MRK | $1.82 | 109.39% | ๐บ๐ธ USA |
AstraZeneca AZN | $1.98 | 128.16% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $3.50 | 302.38% | ๐ฌ๐ง UK |
Agenus
AGEN | -$0.85 | -197.70% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | -$2.00 | -329.89% | ๐ฎ๐ฑ Israel |